药明康德出售药明合联2.47%股权,成交金额约23.46亿港元
Bei Jing Shang Bao·2025-10-09 11:30

Core Viewpoint - WuXi AppTec (603259) announced the sale of 30.3 million shares of WuXi AppTec Holdings, representing 2.47% of the total share capital, for approximately HKD 2.346 billion, which is 3.67% of the company's latest audited net assets attributable to shareholders [1] Group 1: Financial Impact - The cash proceeds from the sale will be used to accelerate global capacity and capability building, attract and retain talent, and strengthen the company's integrated CRDMO business model to meet the growing and changing demands of global clients and patients [1] - The net investment gain from the sale is estimated to impact the company's after-tax net profit for the fiscal year 2025 by approximately CNY 1.679 billion, accounting for over 10% of the latest audited net profit attributable to shareholders [1]